which of the following alpha glucosidase inhibitor doesn't require dose reduction in renal failure
A. Acrabose
B. Voglibose
C. Miglitolol
D. None of the above
ref: Masanori Ab et al., Antidiabetic Agents in Patients with Chronic Kidney Disease and End-Stage Renal Disease on Dialysis: Metabolism and Clinical Practice. Current Drug Metabolism, 2011, 12, 57-69.
| Alpha glucosidase inhibitors | Acarbose | Dose adjustment required in renal failure |
| Miglitol | Dose adjustment required in renal failure | |
| Voglibose | No dose adjustment necessary in renal failure |